- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
City of Hope | Strategic Alliance Partners
Latest from City of Hope
Dr Shouse on AEs Associated With Targeted Therapies in FL
August 20, 2024
Video
Geoffrey Shouse, DO, PhD, discusses adverse effects associated with targeted therapies used to treat patients with follicular lymphoma.
TRANSCEND CLL 004 Data Review and its Impact on Future Treatment Practices
August 15, 2024
Video
Key opinion leaders analyze the implications of the FDA's accelerated approval for lisocabtagene maraleucel (liso-cel) in chronic lymphocytic leukemia, based on promising results from the TRANSCEND CLL 004 trial.
Experts Review Pirtobrutinib Clinical Data and Share its Utilization in Practice
August 15, 2024
Video
A medical expert offers commentary on the recent FDA accelerated approval of pirtobrutinib, discussing the implications of the BRUIN trial findings that supported this decision for chronic lymphocytic leukemia treatment.
Targeted Therapy Combinations Could Represent Next Wave of Treatments in Follicular Lymphoma
August 15, 2024
Article
Geoffrey Shouse, DO, PhD, discusses the benefits of utilizing targeted therapy approaches in the treatment of patients with follicular lymphoma.
Dr Shouse on Currently Available Targeted Therapies for FL
August 13, 2024
Video
Geoffrey Shouse, DO, PhD, discusses currently available targeted therapies for the management of follicular lymphoma.
Dr Danilov on the Importance of Using BTK as a Target in CLL Treatment
August 06, 2024
Video
Alexey Danilov, MD, PhD, discusses the importance of using BTK as a target, as well as recent updates on BTK degraders within the CLL treatment paradigm.
Chemotherapy-Free Approaches Are at the Forefront in MCL
August 05, 2024
Article
Alexey Danilov, MD, PhD, highlights non-chemotherapy options for the treatment of mantle cell lymphoma and expands on ongoing research in hematologic malignancies.
Dr Phillips on the Evolution of MDS Treatment
July 18, 2024
Video
Tycel Phillips, MD, discusses the evolution of treatment for patients with myelodysplastic syndromes, highlighting the future of this treatment paradigm.
City of Hope CAR T-Cell Therapy for Advanced Prostate Cancer Demonstrates Positive Results in Phase 1 Clinical Trial
July 15, 2024
Article
Preliminary data from a first-in-human phase 1 trial using a CAR T-cell therapy developed by City of Hope researchers has been published in Nature Medicine.
Dr Pal on the Preliminary Efficacy of DFF332 in Advanced ccRCC
July 11, 2024
Video
Sumanta Kumar Pal, MD, FASCO, discusses preliminary findings from a phase 1 dose-escalation study of DFF332 in patients with advanced ccRCC.
Dr Krishnan on Patient Characteristics Associated With Early Relapse in Multiple Myeloma
July 11, 2024
Video
Amrita Krishnan, MD, discusses the characteristics and factors associated with a higher risk of early relapse for patients with multiple myeloma.
Dr Danilov on the Evolution of MCL Treatment
July 11, 2024
Video
Alexey Danilov, MD, PhD, discusses the evolution of treatment for patients with mantle cell lymphoma.
Dr Phillips on Evolving Treatment Strategies in Both MCL and CLL
July 11, 2024
Video
Tycel Phillips, MD, discusses the evolution of treatment strategies for patients with either chronic lymphocytic leukemia or mantle cell lymphoma.
Phillips Discusses Past Progress and Previews the Future in Hematologic Cancers
July 10, 2024
Article
Tycel Phillips, MD, highlights key takeaways in NHL, MDS, and myelofibrosis from an OncLive State of the Science Summit on hematology.
Dr Phillips on the Evolution of BTK Inhibitors in MCL
July 03, 2024
Video
Tycel Phillips, MD, discusses the evolution of treatment with BTK inhibitors for patients with mantle cell lymphoma.
Early Data With DFF332, Other Key Biomarker Analyses Continue to Inform Approaches in RCC
July 03, 2024
Article
Sumanta Kumar Pal, MD, FASCO, highlights key renal cell carcinoma research presented at the 2024 ASCO Annual Meeting, including early data with DFF332.
Dr Phillips on the Evolution of the MCL Treatment Paradigm
June 28, 2024
Video
Tycel Phillips, MD, discusses the evolution of treatment for patients with mantle cell lymphoma.
Ongoing Research Efforts and More in Ph+ Acute Lymphoblastic Leukemia
June 21, 2024
Video
Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss ongoing research efforts in the treatment paradigm of Philadelphia chromosome–positive acute lymphoblastic leukemia.
Safety Data With Ponatinib in PHALLCON for Ph+ Acute Lymphoblastic Leukemia
June 21, 2024
Video
Ibrahim T. Aldoss, MD; and Elias Jabbour, MD, discuss safety findings from the PHALLCON trial of ponatinib in Philadelphia chromosome–positive acute lymphoblastic leukemia.